C9H14BrNO, monoclinic, C1c1 (no. 9), a = 6.079(1) Å, b = 19.095(4) Å, c = 8.169(1) Å, β = 95.23(1)°, V = 944.2 Å3, Z = 4, Rgt(F) = 0.047, wRref(F2) = 0.120, T = 293 K
C14H13BrN2O, monoclinic, P21 (no. 4), a = 6.8679(5) Å, b = 7.7096(5) Å, c = 12.4043(7) Å, β = 101.33...
C9H12BrN3O3, monoclinic, P21/c, a = 12.0359(15) Å, b = 5.4815(6) Å, c = 20.1931(18) Å, β = 120.780(5...
C6H7BrN2O2S, monoclinic, P21/c (no. 14), a = 11.2669(5) Å, b = 8.3859(3) Å, c = 19.4047(8) Å, β = 95...
C17H15N2BrO, monoclinic, P21/n (no. 14), a = 8.9886(8) Å, b = 8.2159(7) Å, c = 20.164(2) Å, β = 92.5...
C23H16BrNO, triclinic, P1‾$P‾{1}$ (no. 2), a = 9.914(3) Å, b = 10.141(3) Å, c = 10.179(3) Å, ...
C16H16BrNO4S, monoclinic, P21/c (no. 14), a = 9.649(4) Å, b = 15.108(4) Å, c = 14.994(5) Å, β = 128....
The title compound, C10H8BrNO2, crystallizes with two independent molcules (A and B) in the asymmetr...
In the title compound, C21H19BrN2O2·C2H6OS, the indole ring system is essentially planar, with a max...
C18H19BrN2O5, triclinic, P1̅ (no. 2), a = 9.0429(7) Å, b = 9.5752(11) Å, c = 11.8422(15) Å, α = 7...
C19H19BrN2O5, monoclinic, P21/c (no. 14), a = 10.2634(5) Å, b = 10.7951(4) Å, c = 17.0558(8) Å, β...
C22H19BrN2O, monoclinic, P21/n (no. 14), a = 8.0338(16) Å, b = 9.0803(18) Å, c = 24.281(5) Å, β = 95...
In the title compound, C21H19BrN2O2·C2H6OS, the indole ring system is essentially planar, with a max...
The crystal structure of the title compound, C17H15BrN2O2, has been determined at room temperature. ...
The crystal structure of the title compound, C17H15BrN2O2, has been determined at room temperature. ...
C13H8Br2N2OS2, monoclinic, Pc (no. 7), a = 13.4050(4) Å, b = 4.7716(1) Å, c = 11.7303(4) Å, β = 105....
C14H13BrN2O, monoclinic, P21 (no. 4), a = 6.8679(5) Å, b = 7.7096(5) Å, c = 12.4043(7) Å, β = 101.33...
C9H12BrN3O3, monoclinic, P21/c, a = 12.0359(15) Å, b = 5.4815(6) Å, c = 20.1931(18) Å, β = 120.780(5...
C6H7BrN2O2S, monoclinic, P21/c (no. 14), a = 11.2669(5) Å, b = 8.3859(3) Å, c = 19.4047(8) Å, β = 95...
C17H15N2BrO, monoclinic, P21/n (no. 14), a = 8.9886(8) Å, b = 8.2159(7) Å, c = 20.164(2) Å, β = 92.5...
C23H16BrNO, triclinic, P1‾$P‾{1}$ (no. 2), a = 9.914(3) Å, b = 10.141(3) Å, c = 10.179(3) Å, ...
C16H16BrNO4S, monoclinic, P21/c (no. 14), a = 9.649(4) Å, b = 15.108(4) Å, c = 14.994(5) Å, β = 128....
The title compound, C10H8BrNO2, crystallizes with two independent molcules (A and B) in the asymmetr...
In the title compound, C21H19BrN2O2·C2H6OS, the indole ring system is essentially planar, with a max...
C18H19BrN2O5, triclinic, P1̅ (no. 2), a = 9.0429(7) Å, b = 9.5752(11) Å, c = 11.8422(15) Å, α = 7...
C19H19BrN2O5, monoclinic, P21/c (no. 14), a = 10.2634(5) Å, b = 10.7951(4) Å, c = 17.0558(8) Å, β...
C22H19BrN2O, monoclinic, P21/n (no. 14), a = 8.0338(16) Å, b = 9.0803(18) Å, c = 24.281(5) Å, β = 95...
In the title compound, C21H19BrN2O2·C2H6OS, the indole ring system is essentially planar, with a max...
The crystal structure of the title compound, C17H15BrN2O2, has been determined at room temperature. ...
The crystal structure of the title compound, C17H15BrN2O2, has been determined at room temperature. ...
C13H8Br2N2OS2, monoclinic, Pc (no. 7), a = 13.4050(4) Å, b = 4.7716(1) Å, c = 11.7303(4) Å, β = 105....
C14H13BrN2O, monoclinic, P21 (no. 4), a = 6.8679(5) Å, b = 7.7096(5) Å, c = 12.4043(7) Å, β = 101.33...
C9H12BrN3O3, monoclinic, P21/c, a = 12.0359(15) Å, b = 5.4815(6) Å, c = 20.1931(18) Å, β = 120.780(5...
C6H7BrN2O2S, monoclinic, P21/c (no. 14), a = 11.2669(5) Å, b = 8.3859(3) Å, c = 19.4047(8) Å, β = 95...
DOI
Add to ORKG